STOCK TITAN

SEALSQ Corp (LAES) VP sells 15,000 shares after exercising options

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

SEALSQ Corp Vice President Jean-Pierre Enguent exercised employee stock options for 15,000 Ordinary Shares at $0.01 per share on 2026-08-03, then on 2026-08-05 sold 15,000 Ordinary Shares at a weighted-average price of $2.4571 per share, with both transactions effected under a Rule 10b5-1 trading plan adopted on October 13, 2025.

Positive

  • None.

Negative

  • None.
Insider Enguent Jean-Pierre
Role Vice President, R&DSS
Sold 15,000 shs ($37K)
Approx. gross sale proceeds $37K
Approx. exercise cost $150.00
Type Security Shares Price Value
Sale Ordinary Shares F1, F2 15,000 $2.4571 $37K
Exercise Employee Stock Option Plan (right to buy) F3 15,000 $0.00 $0.00
Exercise Ordinary Shares 15,000 $0.01 $150.00
Holdings After Transaction: Employee Stock Option Plan (right to buy) — 15,000 shares (Direct); Ordinary Shares — 0 shares (Direct)
Footnotes (3)
  1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4313 to $2.51, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. F3. The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
Ordinary Shares sold 15,000 shares Sale of Ordinary Shares on 2026-08-05 by Vice President Jean-Pierre Enguent
Weighted-average sale price $2.4571 per share Weighted-average price for 15,000 Ordinary Shares sold, with trades from $2.4313 to $2.51
Shares acquired on option exercise 15,000 shares Ordinary Shares received upon option exercise on 2026-08-03
Option exercise price $0.01 per share Exercise price for Employee Stock Option Plan (right to buy) underlying 15,000 Ordinary Shares
Option expiration date 2032-04-30 Expiration date of the Employee Stock Option Plan (right to buy)
Net buy/sell shares 15,000 shares Net buy/sell activity reported as net-sell in the transaction summary for this Form 4
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Option Plan financial
"Employee Stock Option Plan (right to buy)"
underlying security financial
"underlying security title: Ordinary Shares, underlying security shares: 15000.0000"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did SEALSQ (LAES) report for Jean-Pierre Enguent?

Jean-Pierre Enguent executed two related transactions: he exercised employee stock options for 15,000 Ordinary Shares at $0.01 per share on 2026-08-03, then sold 15,000 Ordinary Shares on 2026-08-05 at a weighted-average price of $2.4571 per share.

How many SEALSQ (LAES) shares were sold and at what prices?

The filing shows a sale of 15,000 Ordinary Shares at a weighted-average price of $2.4571 per share. Footnotes state the shares were sold in multiple transactions at prices ranging from $2.4313 to $2.51, inclusive, in the open market or private transactions.

What stock options did Jean-Pierre Enguent exercise in SEALSQ (LAES)?

Enguent exercised an Employee Stock Option Plan grant covering 15,000 shares with an exercise price of $0.01 per share. The derivative security related to Ordinary Shares and carried an expiration date of 2032-04-30, according to the Form 4 data.

Were the SEALSQ (LAES) insider transactions made under a Rule 10b5-1 plan?

Yes. Footnotes state both the sale of 15,000 Ordinary Shares and the option exercise for 15,000 shares were effected under a Rule 10b5-1 trading plan adopted by Jean-Pierre Enguent on October 13, 2025.

What does the transaction summary show for SEALSQ (LAES) in this Form 4?

The transaction summary reports 0 shares bought, 15,000 shares sold, and 15,000 shares exercised from derivatives, resulting in net buy/sell activity of −15,000 shares labeled as “net-sell” direction for this reporting period.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Enguent Jean-Pierre

(Last)(First)(Middle)
C/O SEALSQ CORP
AVENUE LOUIS-CASAI 58

(Street)
COINTRIN1216

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
SEALSQ Corp [ LAES ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Vice President, R&DSS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares08/03/2026M15,000A$0.0115,000D
Ordinary Shares08/05/2026(1)S15,000D$2.4571(2)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option Plan (right to buy)$0.0108/03/2026(3)M15,00005/01/202604/30/2032Ordinary Shares15,000$015,000D
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4313 to $2.51, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
3. The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
/s/ John O'Hara, Attorney-in-Fact08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)